I find this part of the news very interesting. Lets cross our fingers.
"According to Henry Gosebruch, managing director of health-care mergers and acquisitions at JPMorgan Chase & Co, the analyst firm expects "the large biotechs to be active acquirers in 2012."
My posts are my opinions only. Do your own DD before you invest in any stock.